Please assess the completion status of the following clinical trial:

Trial Title: Paracetamol and Neuropathic Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient aged 18 to 65 years,~* Patient suffering from chronic pain (for more than 3 months) with the characteristics of peripheral neuropathy and having pain assessed by a numerical scale ≥ 3 for one week, with at least 10 assessments completed,~* Patient agrees with not to take paracetamol, other than the treatment provided as part of the protocol, from inclusion to completion of the study,~* Acceptance to give a written consent.~Exclusion Criteria:~* Patient taking paracetamol daily,~* Patient with a contraindication to paracetamol administration (liver or renal failure, ...),~* Patient with a biological evaluation evaluated by the investigator as not compatible with the trial,~* Patient with a medical and/or surgical history evaluated by the investigator to be not compatible with the trial,~* Patient with drug treatments evaluated by the investigator to be not compatible with the trial,~* Pregnant or nursing woman,~* Patient with a cooperation and an understanding that does not allow for a strict compliance under the conditions set out in the protocol,~* Patient participating in another clinical trial, or being in an exclusion period, or having received a total amount of compensation exceeding 4500 euros over the 12 months preceding the start of the trial,~* Patient benefiting from a legal protection measure (curatorship, guardianship, protection of justice...),~* Patient not affiliated to the French Social Security system,~* Paracetamol intake during wash-out period.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Paracetamol and placebo comparator (Group 1) (Type: OTHER): Neuropathic pain patients taking either paracetamol or placebo according to the randomization plan
- Paracetamol and placebo comparator (Group 2) (Type: OTHER): Neuropathic pain patients taking either paracetamol (if during period 1 they received placebo) or placebo (if during period 1 they received paracetamol)

Based on this trial design, predict the completion outcome and termination type (if applicable).